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Abstract 
Purpose: To investigate the effects of adiponectin (ADPN), free fatty acids (FFAs), growth hormone 
(GH), and dexamethasone (DEX) on miR-378 expression in human adipose tissue cells, and their 
influence on regulation of obesity and insensitivity to insulin. 
Methods: Human pre-adipocytes were cultured and differentiated. Adipocytes were treated with ADPN, 
FFAs, GH and DEX. RNA was isolated and quantified by real-time polymerase chain reaction (RT-
PCR). 
Results: Stimulation with FFA led to significant up-regulation of the expression of MiR-378 
(approximately 3.8-fold) relative to control at the 4th hour (p < 0.01) in human mature adipose tissue 
cells. The expression of MiR-378 was increased almost 1.5-fold by ADPN within 24 h, relative to 
untreated control (p < 0.05). 
Conclusion: The results of this study demonstrate that miR-378 expression is influenced by FFAs, 
ADPN, and DEX, the interaction of which may be involved in the pathogenesis of obesity-induced 
insensitivity to insulin. Thus, miR-378 is a potential biomarker for predicting the risk of complications, 
especially insulin resistance in obesity 
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The typical feature of obesity is body fat in 
excess of what is normal, arising from imbalance 
between energy intake and energy expenditure 
[1]. Childhood and adult obesity are two of the 
most critical threats to health in recent decades 
[2,3]. Obesity is caused by several factors, and 
its pathogenesis involves interplay of social, 
genetic and environmental considerations [4]. A 
plethora of evidence point to the important roles 
of genetic factors in the etiology of obesity. It has 
been reported that ADPN delays and suppresses 
diabetes-associated metabolic derangements [5]. 
It was recently demonstrated that the adipose 
tissue of obese individuals contains excess 
levels of FFAs, a situation considered important 
in obesity and insulin resistance [6]. However, 
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the bases of the influences of ADPN, FFAs, GH 
and DEX on insulin sensitivity and obesity remain 
unclear. 
 
MicroRNAs (miRNAs) are small (19~22 
nucleotides), double-stranded RNAs that repress 
translation and/or destabilize mRNA [7]. One of 
these miRNAs, miR-378 is involved in the 
regulation of lipid metabolism [8,9]. In this study, 
the effects of ADPN, FFAs, GH and DEX on miR-
378 expression in mature adipocytes were 
investigated with a view to unraveling the 





Human pre-adipocytes culture and 
differentiation 
 
Human pre-adipocytes (ScienCell Research 
Laboratories) were cultured in Pre-adipocyte 
Medium (PAM; ScienCell Research Laboratories) 
containing 5 % fetal bovine serum (FBS), 1 % 
pre-adipocyte growth supplement (PAGS), and 1 
% streptomycin/penicillin solution (S/P) at 37 °C 
in a humidified atmosphere with 5 % CO2. For 
induction of differentiation, confluent cells (day 0) 
were maintained in serum-free PAM (SF-PAM) to 
which 100nM DEX, 50 nM insulin, 100 μM 
rosiglitazone and 0.5 mM 3-isobutyl-1-
methylxanthine were added. The culture medium 
was replaced twice within four days at 48h- 
intervals. Subsequently, it was replaced with SF-
PAM to which 50 nM insulin was added. The 
medium was renewed every 48h until the 
appearance of fat droplets on the 15th day. Lipid 
production was measured by Oil Red O staining. 
 
Treatment with ADPN, FFAs, GH and DEX 
 
On day 15 following differentiation, the mature 
human adipocytes were incubated overnight in 
SF-PAM and thereafter treated with 3 ug/mL 
ADPN (Abcam), 1 mmol/L FFA mixture 
containing lauric, myristic, oleic, linoleic and 
arachidonic acids (Sigma); 10 ng/mL GH (Sigma) 
and 1 mM DEX (Biosharp). Three durations of 
exposure were used i.e. 4h, 8h and 24 h. After 
each period of exposure, the cells were 
harvested and used for further investigations 
[10,11]. 
 
RNA extraction and quantitation with RT-PCR  
 
The extraction of total RNA was carried out with 
TRIzol reagent (Invitrogen). The amount of 
extracted RNA was determined 
spectrophotometrically using One Drop 
Spectrophotometer (Qite) with appropriate 
standards. Relative fold-increases in expressions 
were computed using comparative CT 
procedure. Total RNA (200ng) was used to 
synthesize complementary DNA (cDNA) using 
TaqMan microRNA Reverse Transcriptase Kit 
(ABI) according to manufacturer’s protocol. 
Applied Biosystems 7500 Sequence Detection 
System was used for Real-time RT-PCR as 
specified in the manufacturer’s manual. Initial 
denaturation was effected by incubation of 
samples at 95 °C for 10 min, and thereafter with 
40 cycles of PCR for 15 sec at 95 °C, and for 60 
sec at 60 °C. All reactions were carried out in 
triplicate. Relative expressions were calculated 




One-way analysis of variance (ANOVA) was 
used for data analysis with version 16 of SPSS. 
The results are expressed as mean ± SE. Values 
of p < 0.05 were taken as indicative of 




Effect of ADPN on expression of miR-378  
 
Figure 1 shows the differentiation of human pre-
adipocytes into mature adipocytes. The results 
on Figure 2 show the effect of 3 ug/mL ADPN 
treatment at 4, 8 and 24 h on expression of miR-
378, 15 days post-differentiation. Exposure to 
ADPN provoked time-determined increases in 
miR-378 expression, which continued up to 24 h. 
At 24 h, the expression of miR-378 in the ADPN-
treated adipocytes was almost 0.5-fold higher 
than in the control (p < 0.05, Figure 2A). 
 
Effect of FFAs on expression of miR-378  
 
The effect of FFAs on miR-378 expression in 
cultured human adipocytes was analyzed using 
qPCR treatment. The adipose tissue cells were 
exposed in culture to 1 mM FFA cocktail. The 
results on Figure 3 A indicate that miR-378 
expression at 4 h was up-regulated almost 3.8-
fold relative to the control group by FFA (p < 
0.01). The up-regulation continued up to 8 h and 
subsequently, the expression began to decrease, 
although it still showed statistical significance up 
to 24 h. 
 
Effects of GH on expression of miR-378 in 
mature human adipose tissue cells 
 
There were no significant differences in miR-378 
expression between GH-treated and untreated 
groups (Figure 4). 
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Figure 1: Micrograph of differentiated human pre-
adipocytes (day 15), showing fat droplets. (Oil Red O 
stain) 
Effect of DEX on expression of miR-378 in 
mature human adipose tissue cells 
 
The expression of miR-378 was increased 
almost 1.5 folds after 24 h by 1mM DEX, relative 
to control (p < 0.05, Fig. 5A). 
 
MiR-103 as an endogenous control 
 
The stable microRNA transcript, miR-103 was 
employed as internal control for verifying the 
results obtained in miR-378 studies. There were 
similarities in the results obtained (Figures 2 B, 




Figure 2: Effect of ADPN on miR-378 expression in mature human adipose tissue cells determined by 
quantitative RT-PCR relative to that of snRU6 (A) or miR-103 (B). Values are shown as mean ± SE; *p < 0.05 




Figure 3: Effect of FFAs on miR-378 expression in mature human adipose tissue cells. The cells were exposed 
to 1 mmol/L FFAs for various lengths of time, and the amounts of miR-378 were determined with quantitative RT-
PCR relative to the level of snRU6 (A) or miR-103 (B). Values are mean ± SE (n = 3); *p < 0.05, **p < 0.01 when 
compared with values for control 
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Figure 4: Effect of GH on the expression of miR-378 in mature human adipose tissue cells, determined by 




Figure 5: Effect of DEX on miR-378 expression in mature human adipose tissue cells as a function of length of 
exposure, determined using quantitative RT-PCR relative to snRU6 (A) or miR-103 (B). Values are expressed as 




Existing epidemiological studies have already 
shown that globally, the incidence of obesity has 
increased considerably. Obesity is so common in 
the world today that it is beginning to replace 
malnutrition as the most significant contributor to 
ill-health. Obesity is the causative factor for 
coronary heart disease, hypertension, sleep-
breathing disorders and certain forms of cancer. 
However, type 2 diabetes is by far the most 
devastating complication of obesity. These two 
conditions predispose to development of insulin 
resistance. Obesity refers to excess accumula-
tion of adipose tissue to an extent that negatively 
affects physical and psychosocial wellness [13]. 
Adipocytes affect metabolism through the 
release of FFAs, and secretion of hormones, 
glycerol, adiponectin, leptin and cytokines. The 
release of these substances is accentuated by 
obesity [14]. 
 
MiRNAs refer to a group of small and 
endogenously expressed RNAs that regulate the 
expression of genes post-transcriptionally. The 
potential of miRNAs in disease therapy has 
continued to receive recognition, especially in 
obesity and type 2 diabetes [15]. In an miRNA 
expression array study using total RNA extracted 
from human-derived pre-adipocytes and 
adipocytes to profile changes in miRNA 
expression during adipogenesis, the expressions 
of 70 out of 799 miRNAs assayed were 
significantly changed between non-induced and 
induced adipocytes, indicating the importance of 
miRNAs in adipocyte development [16]. The 
locus of miR-378 is located in PPARGC1B intron, 
and it is highly induced during adipogenesis. 
 
In a study, it was shown that mice genetically 
deficient in miR-378 resisted development of 
obesity from high-fat diet, but exhibited increased 
rate of lipid metabolism in the mitochondrion [17]. 
This indicates the likely involvement of miR-378 
in regulating energy balance and metabolic 
processes in the mitochondria. It has been 
demonstrated that in the process of 
adipogenesis, over-expression of miR-378 
enhanced triglyceride levels due to increased 
rate of de novo lipid synthesis [9]. Moreover, Wei 
Liu et al [18] have shown that hepatic miR-378 is 
a key regulator of insulin signaling. On the basis 
of these reports, it can be hypothesized that 
insulin resistance and obesity may be regulated 
by energy sources and hormones through 
interaction with miR-378. 
 
A study has demonstrated that adiponectin levels 
were decreased in either genetically obese ob/ob 
or diet-induced obese (high-fat-diet) mouse 
model [19]. The minor chronic inflammation seen 
in type 2 diabetes and obesity have also been 
associated with adipokine dysregulation [20]. 
Further studies revealed that adiponectin is an 
anti-inflammatory hormone which increases 
insulin sensitivity through enhancement of β-
oxidation and suppression of hepatic 
gluconeogenesis [21]. Thus adiponectin 
regulates energy metabolism. In the present 
study, the concentration of adiponectin was low 
because its levels are decreased in obesity. 
However, adiponectin treatment (3 ug/ml) 
brought about slight increases in expression of 
miR-378, which reached a peak at 24 h. Based 
on this result, it is suggested that there exists a 
feedback regulation mechanism between 
adiponectin and miR-378. These observations 
suggest that a reduction in adiponectin increases 
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miR-378 expression and contributes to insulin 
resistance.  
 
One major factor that affects insulin resistance is 
presence of FFAs. Type 2 diabetes and obesity 
are associated with high rate of FFAs release, 
which may be responsible for insulin resistance 
seen in both diseases [6]. Recently, it was shown 
that two key ER stress sensors, PERK and IRE-
1α were activated by FFAs, and that the use of 
chemical chaperons to attenuate ER stress 
reduced the expression of pro-inflammatory 
cytokines, leading to enhanced insulin sensitivity 
[22]. The results obtained in this study show 
significant up-regulation of miR-378 expression 4 
h post-FFA exposure, which was sustained to the 
8th hour. Thus, miR-378 may be implicated in the 
pathogenesis of FFAs-associated insulin 
insensitivity. 
 
Growth hormone (GH) has a pronounced lipolytic 
effect, particularly on abdominal fat [23]. It 
stimulates protein synthesis, and enhances fat 
utilization by increasing oxidation in adipocytes 
and triglyceride breakdown. In addition, it exerts 
anti-insulin property by suppressing peripheral 
tissue uptake of glucose and enhancing hepatic 
gluconeogenesis [24]. However, the results 
obtained in this study suggest that GH is not 
associated with miR-378-linked insulin 
insensitivity. 
 
In humans, excess glucocorticoids increase 
adipose tissue mass, and re-distribute fat 
between the central and peripheral depots [25]. 
Glucocorticoids enhance ready availability of 
energy substrates to cope with energy demands 
of stress [26]. In humans, prolonged 
glucocorticoid therapy is linked to central obesity 
and insulin resistance. The present study has 
demonstrated that under in vitro conditions, DEX 
enhanced the expression of miR-378 in mature 
human adipose tissue cells, suggesting an 
interaction between glucocorticoid and miR-378 





The findings of this study demonstrate that miR-
378 expression is influenced by adiponectin, 
FFAs and dexamethasone, but not by GH. Thus, 
up-regulation of miR-378 expression may be 
implicated in the etiology of insulin resistance 
induced by these obesity-associated factors. 
Therefore, miR-378 is a potential biomarker for 
predicting the risk of complications of obesity, 
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